that would be shrewd and interesting. I wonder if it's permitted for x-US co't to buy US oil assets? As long as they pay us at least 1/2 of the $16 book value, I'm OK with it :-)
ACHN has tons of cash, it's probably trading at about 3x cash. If JNJ pays $12.25, ACHN execs should be happy to retire some stock at this price. Yes, I know biotech co's almost never do this, but ACHN has more cash than they need and they can't possible use so much cash unless they buy some assets. I would prefer they buy their own stock vs another bloated asset.
I did, sold puts...That's how you get it cheaper, or just collect income. But...you have to have the cash to buy. Don't do this on margin, it's a strategy for chicken traders to collect some cash or buy stock at a slight discount.
no kidding, the drug is not mass market, it's for a small patient population. It's not a benign pill, it's an expensive biological injection. It has limits, no sh...
S9. I like and respect you as a poster. I look at the chart and all I see is upper left to lower right. JL has done nothing for the shareholders. He promised pipeline value in 15. I guess that he has a few months remaining to make good on this, but the 334 trial has not started and I see very little to encourage me about the next 6 months. JL seems self oriented, clueless, in way over his head and he's not getting the job done (for longs/investors). He's doing a great job for the shorts and they love him! Where's his skin in the game?
If oil does not rise to $70 range in the next 2 years, BBEP is probably finished. Before BBEP goes, many other co's that did not hedge will fail. If oil does recover to $70+ and stay there for a period, the stock should easily return to $8+. Is there's an acquisition is should be at $7-8+. Only low, LT prices will kill the company. I'm betting that at some point in the next 18-24 months oil will recover.
OPEC is being stupid by focusing on market share. Oil is a finite resource, they should be trying to max the return on every barrel, not trying to wipe out the new US Oil market and slowing alternatives. Their strategy is financially foolish. A reasonable price $78-80 with supply/demand in balance is the best LT strategy.
Status still says not yet started WTH. Let's get some sense of urgency, fire in the belly, someone needs to need to light a fire under JL's slow Azz Shareholders are tired of waiting. Get something accomplished that will raise the stock price, or get OUT!
Sold calls, then bought them back. $29 is now resistance. Support should be in the range of $24-25 IMO. Let's see if shorts try to follow up on Cramer's little comment. It's amazing how the sheep follow him, over a cliff, mostly to ruin.
No way ARNA should, or would license to CELG, they would have no incentive to sell the drug. If they want to buy the company, that a different story, Highly unlikely. Next!